Clinical Trial Detail
| NCT ID | NCT02504489 |
| Title | Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC (DUBLIN-3) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | Yes |
| Sponsors | BeyondSpring Pharmaceuticals Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior adult |
CKB BOOST